Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab

IKKO TOMISAKI; MIRII HARADA; SHIGERU SAKANO; MICHIKAZU TERADO; RYOICHI HAMASUNA; SHUJI HARADA; HIROOMI MATSUMOTO; SOICHIRO AKASAKA; YUJIRO NAGATA; AKINORI MINATO; KEN-ICHI HARADA; NAOHIRO FUJIMOTO

doi:10.21873/anticanres.16159

Research ArticleClinical Studies

Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab

IKKO TOMISAKI, MIRII HARADA, SHIGERU SAKANO, MICHIKAZU TERADO, RYOICHI HAMASUNA, SHUJI HARADA, HIROOMI MATSUMOTO, SOICHIRO AKASAKA, YUJIRO NAGATA, AKINORI MINATO, KEN-ICHI HARADA and NAOHIRO FUJIMOTO

Anticancer Research January 2023, 43 (1) 269-274; DOI: https://doi.org/10.21873/anticanres.16159

IKKO TOMISAKI

1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: ikko{at}med.uoeh-u.ac.jp

MIRII HARADA

1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHIGERU SAKANO

2Department of Urology, Kokura Memorial Hospital, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MICHIKAZU TERADO

3Department of Urology, Munakata Suikokai General Hospital, Fukutsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

RYOICHI HAMASUNA

4Department of Urology, Shin-kokura Hospital, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHUJI HARADA

5Department of Urology, Shin-yukuhashi Hospital, Yukuhashi, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROOMI MATSUMOTO

6Department of Urology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SOICHIRO AKASAKA

7Department of Urology, Moji Medical Centre, Kitakyushu, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUJIRO NAGATA

1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

AKINORI MINATO

1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KEN-ICHI HARADA

1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

NAOHIRO FUJIMOTO

1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Kaplan–Meier estimates of progression-free survival (A) and overall survival (B), stratified by body mass index.

Tables

Figures

PreviousNext

In this issue

Anticancer Research

Vol. 43, Issue 1

January 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 17 + 1 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab

IKKO TOMISAKI, MIRII HARADA, SHIGERU SAKANO, MICHIKAZU TERADO, RYOICHI HAMASUNA, SHUJI HARADA, HIROOMI MATSUMOTO, SOICHIRO AKASAKA, YUJIRO NAGATA, AKINORI MINATO, KEN-ICHI HARADA, NAOHIRO FUJIMOTO

Anticancer Research Jan 2023, 43 (1) 269-274; DOI: 10.21873/anticanres.16159

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab

IKKO TOMISAKI, MIRII HARADA, SHIGERU SAKANO, MICHIKAZU TERADO, RYOICHI HAMASUNA, SHUJI HARADA, HIROOMI MATSUMOTO, SOICHIRO AKASAKA, YUJIRO NAGATA, AKINORI MINATO, KEN-ICHI HARADA, NAOHIRO FUJIMOTO

Anticancer Research Jan 2023, 43 (1) 269-274; DOI: 10.21873/anticanres.16159

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World

Google Scholar

Keywords

body mass index
pembrolizumab
Obesity
Urothelial carcinoma

Main menu

User menu

Search

Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords